{"answer":{"query":"Actemra","resolved_as":"applications","packages":7,"applications":["BLA125276","BLA125472"],"identity":{"application_numbers":["BLA125276","BLA125472"],"marketing_categories":["BLA"],"labelers":[],"dosage_forms":[{"text":"INJECTION, SOLUTION, CONCENTRATE","untrusted":true},{"text":"INJECTION, SOLUTION","untrusted":true}],"marketing_start":{"earliest":"2010-01-08","latest":"2018-11-19","packages_with_a_start_date":7}},"label_history":{"events_total":58,"non_cmc_events":58,"counts_by_class":{"LABELING":34,"EFFICACY":22,"REMS":2},"cmc_events":0,"recent_non_cmc_events":[{"application":"BLA125276","submission_no":147,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-12-10","documents":[{"type":"Letter","date":"2025-12-11","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/125276Orig1s147ltr.pdf","untrusted":true}},{"type":"Label","date":"2025-12-12","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125276s147lbl.pdf","untrusted":true}}],"fact_id":"a5a786110c12f65a26585121"},{"application":"BLA125472","submission_no":59,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-12-10","documents":[{"type":"Letter","date":"2025-12-11","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/125472Orig1s059ltr.pdf","untrusted":true}},{"type":"Label","date":"2025-12-12","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125472s059lbl.pdf","untrusted":true}}],"fact_id":"0cdb2854751b54cc92ff16fd"},{"application":"BLA125276","submission_no":149,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2025-08-08","documents":[{"type":"Label","date":"2025-08-11","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125276s149lbl.pdf","untrusted":true}},{"type":"Letter","date":"2025-08-12","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/125276Orig1s149ltr.pdf","untrusted":true}}],"fact_id":"6cdc6d58faf1b13073248f83"},{"application":"BLA125472","submission_no":61,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-08-08","documents":[{"type":"Label","date":"2025-08-11","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125472s061lbl.pdf","untrusted":true}},{"type":"Letter","date":"2025-08-12","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/125472Orig1s061ltr.pdf","untrusted":true}}],"fact_id":"1c63aaa68360810f49703cad"},{"application":"BLA125276","submission_no":146,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2024-12-10","documents":[{"type":"Letter","date":"2024-12-11","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/125472Orig1s058,125276Orig1s146ltr.pdf","untrusted":true}}],"fact_id":"ff7370b36c97989998f5e345"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":4,"te_code_counts":{"NOT_PROVIDED":4},"marketing_status_counts":{"Prescription":4},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"BLA125276","product_no":"003","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"ACTEMRA","untrusted":true},"form":{"text":"INJECTABLE; INJECTION","untrusted":true},"strength":{"text":"400MG/20ML","untrusted":true}},{"application":"BLA125276","product_no":"002","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"ACTEMRA","untrusted":true},"form":{"text":"INJECTABLE; INJECTION","untrusted":true},"strength":{"text":"200MG/10ML","untrusted":true}},{"application":"BLA125276","product_no":"001","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"ACTEMRA","untrusted":true},"form":{"text":"INJECTABLE; INJECTION","untrusted":true},"strength":{"text":"80MG/4ML","untrusted":true}},{"application":"BLA125472","product_no":"001","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"ACTEMRA","untrusted":true},"form":{"text":"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","untrusted":true},"strength":{"text":"162MG/0.9ML","untrusted":true}}]},"spending":{"reported_under":{"generic":{"text":"Tocilizumab","untrusted":true},"brand":{"text":"Actemra*","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":127856836.18,"claims":32917,"beneficiaries":4668,"average_spending_per_claim_usd":3884.2189805,"fact_id":"7e8dfc8999b91c62749e97e1"},{"year":2021,"gross_spending_usd":123904981.19,"claims":32334,"beneficiaries":5123,"average_spending_per_claim_usd":3832.0338093,"fact_id":"0b31d8270e4f6c1654182abb"},{"year":2022,"gross_spending_usd":127758478.59,"claims":33653,"beneficiaries":4885,"average_spending_per_claim_usd":3796.3473863,"fact_id":"61758d0bc7953aae988bed36"},{"year":2023,"gross_spending_usd":135711700.12,"claims":33939,"beneficiaries":4570,"average_spending_per_claim_usd":3998.6947205,"fact_id":"1d262ecf9e1ae77858df8114"},{"year":2024,"gross_spending_usd":131902218.48,"claims":34207,"beneficiaries":4779,"average_spending_per_claim_usd":3856.0007741,"fact_id":"e41aaca30cfb454dd99058de"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"biologic_status":{"products":[{"application":"BLA125276","status":"Reference","name":{"text":"Actemra","untrusted":true},"proper_name":{"text":"tocilizumab","untrusted":true},"license_status":"Licensed","approval_date":"2010-01-08","reference_product":null,"interchangeable_date":null,"biosimilars_listed":3,"interchangeables_listed":2,"biosimilars":[{"name":{"text":"Tyenne","untrusted":true},"proper_name":{"text":"tocilizumab-aazg","untrusted":true},"bla_number":"761275","approval_date":"2024-03-05","interchangeable_date":null},{"name":{"text":"Tofidence","untrusted":true},"proper_name":{"text":"tocilizumab-bavi","untrusted":true},"bla_number":"761354","approval_date":"2023-09-29","interchangeable_date":null},{"name":{"text":"Tyenne","untrusted":true},"proper_name":{"text":"tocilizumab-aazg","untrusted":true},"bla_number":"761449","approval_date":"2025-03-14","interchangeable_date":null}],"interchangeables":[{"name":{"text":"Avtozma","untrusted":true},"proper_name":{"text":"tocilizumab-anoh","untrusted":true},"bla_number":"761420","approval_date":"2025-01-24","interchangeable_date":"2025-01-24"},{"name":{"text":"Avtozma","untrusted":true},"proper_name":{"text":"tocilizumab-anoh","untrusted":true},"bla_number":"761498","approval_date":"2025-01-24","interchangeable_date":"2025-01-24"}],"purple_book_version":"purplebook-2026-10","read_on":"2026-11-07T07:33:31.186Z","fact_id":"689639634dd105d10496e3f0"},{"application":"BLA125472","status":"Reference","name":{"text":"Actemra","untrusted":true},"proper_name":{"text":"tocilizumab","untrusted":true},"license_status":"Licensed","approval_date":"2013-10-21","reference_product":null,"interchangeable_date":null,"biosimilars_listed":3,"interchangeables_listed":2,"biosimilars":[{"name":{"text":"Tyenne","untrusted":true},"proper_name":{"text":"tocilizumab-aazg","untrusted":true},"bla_number":"761275","approval_date":"2024-03-05","interchangeable_date":null},{"name":{"text":"Tofidence","untrusted":true},"proper_name":{"text":"tocilizumab-bavi","untrusted":true},"bla_number":"761354","approval_date":"2023-09-29","interchangeable_date":null},{"name":{"text":"Tyenne","untrusted":true},"proper_name":{"text":"tocilizumab-aazg","untrusted":true},"bla_number":"761449","approval_date":"2025-03-14","interchangeable_date":null}],"interchangeables":[{"name":{"text":"Avtozma","untrusted":true},"proper_name":{"text":"tocilizumab-anoh","untrusted":true},"bla_number":"761420","approval_date":"2025-01-24","interchangeable_date":"2025-01-24"},{"name":{"text":"Avtozma","untrusted":true},"proper_name":{"text":"tocilizumab-anoh","untrusted":true},"bla_number":"761498","approval_date":"2025-01-24","interchangeable_date":"2025-01-24"}],"purple_book_version":"purplebook-2026-10","read_on":"2026-11-07T07:33:31.186Z","fact_id":"4b8dd7a6e7b68440fc743ed2"}],"reading":"what the FDA Purple Book lists on its read date, a record and not a forecast of launch or substitution"},"payment_limit":{"codes":[{"hcpcs":"J3262","quarter":"2026Q4","effective":"October 1, 2026 through December 31, 2026","payment_limit_usd":5.325,"dosage_descriptor":{"text":"1 MG","untrusted":true},"packages_matched":3,"read_on":"2026-11-07T07:31:28.000Z","source_url":{"text":"https://www.cms.gov/medicare/payment/part-b-drugs/asp-pricing-files","untrusted":true},"fact_id":"4b054226682ae604538aa0f4"}],"codes_total":1,"meaning":"a Medicare Part B payment ceiling for providers billing a HCPCS code, per dosage descriptor unit; not a price a patient pays, and the presence of a code does not indicate that Medicare covers a product"},"rems":{"programs":[{"application":"BLA125276","program":{"text":"Actemra","untrusted":true},"rems_id":"1","in_force":false,"released":true,"moved_to_shared_system":false,"has_etasu":false,"program_date":"2010-01-08","last_modified":"2015-08-18","source_page":"https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=IndvRemsDetails.page&REMS=1","other_programs":0,"read_on":"2026-11-07T20:05:28.959Z","fact_id":"f8d5f7b99c582a7b141a38c3"},{"application":"BLA125472","program":{"text":"Actemra","untrusted":true},"rems_id":"1","in_force":false,"released":true,"moved_to_shared_system":false,"has_etasu":false,"program_date":"2010-01-08","last_modified":"2015-08-18","source_page":"https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=IndvRemsDetails.page&REMS=1","other_programs":0,"read_on":"2026-11-07T20:05:28.959Z","fact_id":"a9fac9a4559add1d4b9148bf"}],"reading":"what the FDA REMS@FDA files tie to the application on the read date; it does not say which prescribers or pharmacies take part or whether a patient needs the program"},"orphan_designation":{"ingredients":[{"ingredient":{"text":"tocilizumab","untrusted":true},"designation_count":5,"approved_count":4,"recent":[{"designated":"2025-12-05","use":{"text":"treatment of Takayasu arteritis","untrusted":true},"status":"Designated","sponsor":{"text":"ODDIFACT SAS","untrusted":true},"approved":false},{"designated":"2017-08-01","use":{"text":"Treatment of chimeric antigen receptor (CAR) T cell-induced cytokine release syndrome","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"Genentech Inc., a member of the Roche Group","untrusted":true},"approved":true},{"designated":"2013-04-17","use":{"text":"Treatment of systemic sclerosis","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"Genentech, Inc.","untrusted":true},"approved":true},{"designated":"2012-07-31","use":{"text":"Treatment of pediatric patients (age 16 years and younger) with polyarticular-course juvenile idiopathic arthritis","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"Genentech, Inc.","untrusted":true},"approved":true},{"designated":"2012-07-31","use":{"text":"Treatment of pediatric patients (age 16 years and younger) with polyarticular-course juvenile idiopathic arthritis","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"Genentech, Inc.","untrusted":true},"approved":true}],"read_on":"2026-11-07T12:00:00.000Z","fact_id":"742279597d456236b1178b13"}],"reading":"a designation is not an approval and not a statement that the drug treats the condition; status is the FDA database's own"},"medicaid_state_utilization":{"year":2025,"states_with_data":10,"all_states_medicaid_reimbursed_usd":1991776.81,"all_states_medicaid_paid_prescriptions":1104,"top_states":[{"state":"ME","medicaid_paid_prescriptions":103,"medicaid_reimbursed_usd":417729.68,"total_reimbursed_usd":417729.68,"packages":1,"covers":"all_record_types","fact_id":"eac93d616e9ca4a0b5712d34"},{"state":"OK","medicaid_paid_prescriptions":84,"medicaid_reimbursed_usd":276192.53,"total_reimbursed_usd":280780.86,"packages":1,"covers":"fee_for_service_only","fact_id":"bd2f663f9a97ac280ff4c374"},{"state":"NE","medicaid_paid_prescriptions":145,"medicaid_reimbursed_usd":267076.73,"total_reimbursed_usd":296685.43,"packages":2,"covers":"all_record_types","fact_id":"1df3220beed09659c357a241"},{"state":"AR","medicaid_paid_prescriptions":192,"medicaid_reimbursed_usd":242076.49,"total_reimbursed_usd":438373.15,"packages":2,"covers":"all_record_types","fact_id":"cdbc71679a1cf0a0fee9bd30"},{"state":"SD","medicaid_paid_prescriptions":57,"medicaid_reimbursed_usd":227108.92,"total_reimbursed_usd":227108.92,"packages":1,"covers":"all_record_types","fact_id":"9c8ec7c242476ca66a032cd9"},{"state":"IA","medicaid_paid_prescriptions":53,"medicaid_reimbursed_usd":169172.64,"total_reimbursed_usd":169172.64,"packages":1,"covers":"all_record_types","fact_id":"bbdd5f272890989df3b659cf"},{"state":"NC","medicaid_paid_prescriptions":68,"medicaid_reimbursed_usd":146649.56,"total_reimbursed_usd":149289.19,"packages":1,"covers":"fee_for_service_only","fact_id":"a914b43f12afb0d71cffd805"},{"state":"AK","medicaid_paid_prescriptions":89,"medicaid_reimbursed_usd":112644.93,"total_reimbursed_usd":316377.44,"packages":1,"covers":"fee_for_service_only","fact_id":"2006a425e9625ddcc49b6a0f"},{"state":"GA","medicaid_paid_prescriptions":268,"medicaid_reimbursed_usd":109831.12,"total_reimbursed_usd":441341.23,"packages":2,"covers":"fee_for_service_only","fact_id":"719c7f983e5c577124d685cc"},{"state":"MS","medicaid_paid_prescriptions":45,"medicaid_reimbursed_usd":23294.21,"total_reimbursed_usd":53978.31,"packages":1,"covers":"fee_for_service_only","fact_id":"85e3f86e84117ab155ca1ab2"}],"unlabelled_state_code_xx":null,"built_from_facts":13,"facts_fee_for_service_only":6,"older_year_facts_not_used":157,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"8ebe752fad1881768d200af3","field":"ndc.listing","entity":"ndc:50242013501"},{"fact_id":"98e82197a9311a4a9d9ecbb6","field":"ndc.listing","entity":"ndc:50242013601"},{"fact_id":"1f4070e6b8c3089c8e1b353a","field":"ndc.listing","entity":"ndc:50242013701"},{"fact_id":"a5a786110c12f65a26585121","field":"drug.label_event","entity":"application:BLA125276"},{"fact_id":"0cdb2854751b54cc92ff16fd","field":"drug.label_event","entity":"application:BLA125472"},{"fact_id":"6cdc6d58faf1b13073248f83","field":"drug.label_event","entity":"application:BLA125276"},{"fact_id":"1c63aaa68360810f49703cad","field":"drug.label_event","entity":"application:BLA125472"},{"fact_id":"ff7370b36c97989998f5e345","field":"drug.label_event","entity":"application:BLA125276"},{"fact_id":"dafcbcea680d8f21e8a3d025","field":"drug.marketing_status","entity":"application:BLA125276"},{"fact_id":"8b544dceee428d542dda3087","field":"drug.marketing_status","entity":"application:BLA125276"},{"fact_id":"1c9db5bde93daa7160ef4eae","field":"drug.marketing_status","entity":"application:BLA125276"},{"fact_id":"0494b9ed00376d862ffd89df","field":"drug.marketing_status","entity":"application:BLA125472"},{"fact_id":"7e8dfc8999b91c62749e97e1","field":"drug.partd_spending","entity":"drug:tocilizumab|actemra"},{"fact_id":"0b31d8270e4f6c1654182abb","field":"drug.partd_spending","entity":"drug:tocilizumab|actemra"},{"fact_id":"61758d0bc7953aae988bed36","field":"drug.partd_spending","entity":"drug:tocilizumab|actemra"},{"fact_id":"1d262ecf9e1ae77858df8114","field":"drug.partd_spending","entity":"drug:tocilizumab|actemra"},{"fact_id":"e41aaca30cfb454dd99058de","field":"drug.partd_spending","entity":"drug:tocilizumab|actemra"},{"fact_id":"689639634dd105d10496e3f0","field":"drug.biologic_status","entity":"application:BLA125276"},{"fact_id":"3158878c4d0951bf5d1635c9","field":"drug.biologic_status","entity":"application:BLA761275"},{"fact_id":"e2b659d6a36e790194a89b00","field":"drug.biologic_status","entity":"application:BLA761354"},{"fact_id":"0745c41af9acfe212a68d8e5","field":"drug.biologic_status","entity":"application:BLA761420"},{"fact_id":"37797112c1c09b2eb45ad803","field":"drug.biologic_status","entity":"application:BLA761449"},{"fact_id":"d3af2e5acc463fbb3cb3fb6c","field":"drug.biologic_status","entity":"application:BLA761498"},{"fact_id":"4b8dd7a6e7b68440fc743ed2","field":"drug.biologic_status","entity":"application:BLA125472"},{"fact_id":"4b054226682ae604538aa0f4","field":"drug.asp_price","entity":"hcpcs:J3262"},{"fact_id":"f8d5f7b99c582a7b141a38c3","field":"drug.rems","entity":"application:BLA125276"},{"fact_id":"a9fac9a4559add1d4b9148bf","field":"drug.rems","entity":"application:BLA125472"},{"fact_id":"742279597d456236b1178b13","field":"drug.orphan_designation","entity":"drug:tocilizumab"},{"fact_id":"eac93d616e9ca4a0b5712d34","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242014301:ME"},{"fact_id":"bd2f663f9a97ac280ff4c374","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242014301:OK"},{"fact_id":"1df3220beed09659c357a241","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242014301:NE"},{"fact_id":"cdbc71679a1cf0a0fee9bd30","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242014301:AR"},{"fact_id":"9c8ec7c242476ca66a032cd9","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242014301:SD"},{"fact_id":"bbdd5f272890989df3b659cf","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242013801:IA"},{"fact_id":"a914b43f12afb0d71cffd805","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242013601:NC"},{"fact_id":"2006a425e9625ddcc49b6a0f","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242013701:AK"},{"fact_id":"719c7f983e5c577124d685cc","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242013501:GA"},{"fact_id":"85e3f86e84117ab155ca1ab2","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50242013501:MS"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"price","reason":"no NADAC price, negotiated price or federal upper limit for these packages"},{"code":"NO_DATA","field":"generic_entry:BLA125276","reason":"no generic-entry fact for this application: no patent or exclusivity is listed for it in the Orange Book edition read, so no date is stated"},{"code":"NO_DATA","field":"generic_entry:BLA125472","reason":"no generic-entry fact for this application: no patent or exclusivity is listed for it in the Orange Book edition read, so no date is stated"},{"code":"NO_DATA","field":"generic_entry","reason":"no application of this drug has a generic-entry fact; no date is stated"},{"code":"NO_DATA","field":"recalls","reason":"no FDA enforcement report naming a package of these applications is recorded"},{"code":"NO_DATA","field":"supply","reason":"no FDA shortage row and no termination date for these packages"},{"code":"NO_DATA","field":"trials","reason":"no ClinicalTrials.gov record set for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"assistance_and_offers","reason":"no assistance program lists this drug and no manufacturer offer naming it is recorded; that does not mean none exists"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}